The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Invasive fungal infections: a review of epidemiology and management options
Abstract
Fungi are increasingly recognised as major pathogens in critically ill patients. Candida spp. and Cryptococcus spp. are the yeasts most frequently isolated in clinical practice. The most frequent filamentous fungi (moulds) isolated are Aspergillus spp., but Fusarium spp., Scedosporium spp., Penicillium spp., and Zygomycetes are increasingly seen. Several reasons have been proposed for the increase in invasive fungal infections, including the use of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics, and prosthetic devices and grafts, and more aggressive surgery. Patients with burns, neutropenia, HIV infection and pancreatitis are also predisposed to fungal infection. The epidemiology and clinical features of fungal infections are reviewed, together with antifungal agents currently or soon to be available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304 · cited 2×
“5 mg kg21 day21) in a non-blinded trial (Herbrecht et al., 2002).”
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Ribes, J. A., Vanover-Sams, C. L., & Baker, D. J. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.2.236 · Cited by 1,711
Denning, D. W. (1998) · Clinical Infectious Diseases · doi:10.1086/513943 · Cited by 1,492
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,448
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131 · cited 2×
“Caspofungin The spectrum of caspofungin (Merck Sharpe & Dohme) is limited to Candida spp., Saccharomyces spp., Pneumocystis carinii and Aspergillus spp., including A. terreus (Denning, 2003).”
BackgroundPractice Guidelines for the Management of Cryptococcal Disease
Saag, M. S., Graybill, R. J., Larsen, R. A., Pappas, P. G., Perfect, J. R., Powderly, W. G., Sobel, J. D., Dismukes, W. E., & Mycoses Study Group Cryptococcal Subproject (2000) · Clinical Infectious Diseases · doi:10.1086/313757 · Cited by 1,105
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszynska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 919
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
Eggimann, P., Garbino, J., & Pittet, D. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00801-6 · Cited by 900
Bennett, J. E., Dismukes, W. E., Duma, R. J., Medoff, G., Sande, M. A., Gallis, H., Leonard, J., Fields, B. T., Bradshaw, M., Haywood, H., et al. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907193010303 · Cited by 863
Slavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 820
Vermes, A. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.171 · Cited by 803
Practice Guidelines for Diseases Caused by Aspergillus
Stevens, D. A., Kan, V. L., Judson, M. A., Morrison, V. A., Dummer, S., Denning, D. W., Bennett, J. E., Walsh, T. J., Patterson, T. F., & Pankey, G. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313756 · Cited by 789
Voriconazole: A New Triazole Antifungal Agent
Johnson, L. B., & Kauffman, C. A. (2003) · Clinical Infectious Diseases · doi:10.1086/367933 · Cited by 785
Caillot, D., Casasnovas, O., Bernard, A., Couaillier, J. F., Durand, C., Cuisenier, B., Solary, E., Piard, F., Petrella, T., Bonnin, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.139 · Cited by 706
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Maertens, J., Raad, I., Petrikkos, G., Boogaerts, M., Selleslag, D., Petersen, F. B., Sable, C. A., Kartsonis, N. A., Ngai, A., Taylor, A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/423381 · Cited by 658
Maertens, J., Theunissen, K., Verhoef, G., Verschakelen, J., Lagrou, K., Verbeken, E., Wilmer, A., Verhaegen, J., Boogaerts, M., & Eldere, J. V. (2005) · Clinical Infectious Diseases · doi:10.1086/496927 · Cited by 592
Caillot, D., Couaillier, J.-F., Bernard, A., Casasnovas, O., Denning, D. W., Mannone, L., Lopez, J., Couillault, G., Piard, F., Vagner, O., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.253 · Cited by 587
Wingard, J. R., White, M. H., Anaissie, E., Raffalli, J., Goodman, J., Arrieta, A., & L Amph/ABLC Collaborative Study Group (2000) · Clinical Infectious Diseases · doi:10.1086/317451 · Cited by 527
Kullberg, B., Sobel, J., Ruhnke, M., Pappas, P., Viscoli, C., Rex, J., Cleary, J., Rubinstein, E., Church, L., Brown, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67490-9 · Cited by 521
Marr, K. A., Seidel, K., Slavin, M. A., Bowden, R. A., Schoch, H. G., Flowers, M. E. D., Corey, L., & Boeckh, M. (2000) · Blood · doi:10.1182/blood.v96.6.2055 · Cited by 511
Tortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1103-y · Cited by 509
Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States
Ostrosky-Zeichner, L., Rex, J. H., Pappas, P. G., Hamill, R. J., Larsen, R. A., Horowitz, H. W., Powderly, W. G., Hyslop, N., Kauffman, C. A., Cleary, J., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3149-3154.2003 · Cited by 498
Rex, J. H., Pappas, P. G., Karchmer, A. W., Sobel, J., Edwards, J. E., Hadley, S., Brass, C., Vazquez, J. A., Chapman, S. W., Horowitz, H. W., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374850 · Cited by 495
Marr, K. A., Crippa, F., Leisenring, W., Hoyle, M., Boeckh, M., Balajee, S. A., Nichols, W. G., Musher, B., & Corey, L. (2004) · Blood · doi:10.1182/blood-2003-08-2644 · Cited by 442
Marty, F. M., Cosimi, L. A., & Baden, L. R. (2004) · New England Journal of Medicine · doi:10.1056/nejm200402263500923 · Cited by 426
Diekema, D. J., Messer, S. A., Hollis, R. J., Jones, R. N., & Pfaller, M. A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3623-3626.2003 · Cited by 371
Sun, Q. N., Fothergill, A. W., McCarthy, D. I., Rinaldi, M. G., & Graybill, J. R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1581-1582.2002 · Cited by 365
Husain, S., Alexander, B. D., Munoz, P., Avery, R. K., Houston, S., Pruett, T., Jacobs, R., Dominguez, E. A., Tollemar, J. G., Baumgarten, K., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375822 · Cited by 337
Ally, R., Schürmann, D., Kreisel, W., Carosi, G., Aguirrebengoa, K., Dupont, B., Hodges, M., Troke, P., Romero, A. J., & the Esophageal Candidiasis Study Group (2001) · Clinical Infectious Diseases · doi:10.1086/322653 · Cited by 331 · cited 1×
“Voriconazole has been compared with fluconazole in the treatment of oesophageal candidiasis, in which it was as effective but was less well tolerated (Ally et al., 2001).”
BackgroundBoogaerts, M., Winston, D. J., Bow, E. J., Garber, G., Reboli, A. C., Schwarer, A. P., Novitzky, N., Boehme, A., Chwetzoff, E., De Beule, K., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00010 · Cited by 321
Leenders, A. C. A. P., Daenen, S., Jansen, R. L. H., Hop, W. C. J., Lowenberg, B., Wijermans, P. W., Cornelissen, J., Herbrecht, R., Lelie, H. V. D., Hoogsteden, H. C., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00944.x · Cited by 319
Villanueva, A., Arathoon, E. G., Gotuzzo, E., Berman, R. S., DiNubile, M. J., & Sable, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/323401 · Cited by 308
White, M. H., Bowden, R. A., Sandler, E. S., Graham, M. L., Noskin, G. A., Wingard, J. R., Goldman, M., van Burik, J., McCabe, A., Lin, J., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/514672 · Cited by 303
Villanueva, A., Gotuzzo, E., Arathoon, E. G., Noriega, L. M., Kartsonis, N. A., Lupinacci, R. J., Smietana, J. M., DiNubile, M. J., & Sable, C. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01191-9 · Cited by 292
Kontoyiannis, D. P., Hachem, R., Lewis, R. E., Rivero, G. A., Torres, H. A., Thornby, J., Champlin, R., Kantarjian, H., Bodey, G. P., & Raad, I. I. (2003) · Cancer · doi:10.1002/cncr.11479 · Cited by 287
Posaconazole: a broad-spectrum triazole antifungal
Torres, H. A., Hachem, R. Y., Chemaly, R. F., Kontoyiannis, D. P., & Raad, I. I. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70297-8 · Cited by 285
Winston, D. J., Pakrasi, A., & Busuttil, R. W. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-10-199911160-00003 · Cited by 261
Denning, D. W., Marinus, A., Cohen, J., Spence, D., Herbrecht, R., Pagano, L., Kibbler, C., Kermery, V., Offner, F., Cordonnier, C., et al. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)80173-4 · Cited by 256
Saag, M. S., Cloud, G. A., Graybill, J. R., Sobel, J. D., Tuazon, C. U., Johnson, P. C., Fessel, W. J., Moskovitz, B. L., Wiesinger, B., Cosmatos, D., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515110 · Cited by 244
Singh, N., Avery, R. K., Munoz, P., Pruett, T. L., Alexander, B., Jacobs, R., Tollemar, J. G., Dominguez, E. A., Yu, C. M., Paterson, D. L., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/345441 · Cited by 240
Spectrum of Aspergillus Infection in Lung Transplant Recipients
Mehrad, B., Paciocco, G., Martinez, F. J., Clark Ojo, T., Iannettoni, M. D., & Lynch, J. P. (2001) · Chest · doi:10.1378/chest.119.1.169 · Cited by 236
Eriksson, U., Seifert, B., & Schaffner, A. (2001) · BMJ · doi:10.1136/bmj.322.7286.579 · Cited by 236
Phillips, P., Shafran, S., Garber, G., Rotstein, C., Smaill, F., Fong, I., Salit, I., Miller, M., Williams, K., Conly, J. M., et al. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01726360 · Cited by 221
Becker, M. J., Lugtenburg, E. J., Cornelissen, J. J., Van Der Schee, C., Hoogsteden, H. C., & De Marie, S. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04308.x · Cited by 217
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi
Johnson, E. M., Szekely, A., & Warnock, D. W. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.6.741 · Cited by 215
Barone, J. A., Moskovitz, B. L., Guarnieri, J., Hassell, A. E., Colaizzi, J. L., Bierman, R. H., & Jessen, L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1862 · Cited by 208
Morgenstern, G. R., Prentice, A. G., Grant Prentice, H., Ropner, J. E., Schey, S. A., Warnock, D. W., & on behalf of the U.K. Multicentre Antifungal Prophylaxis Study Group (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01465.x · Cited by 201
Denning, D. W., Kibbler, C. C., & Barnes, R. A. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00580-2 · Cited by 194
Steinbach, W. J., Stevens, D. A., & Denning, D. W. (2003) · Clinical Infectious Diseases · doi:10.1086/376524 · Cited by 192
A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations
Barrett, J. P., Vardulaki, K. A., Conlon, C., Cooke, J., Daza-Ramirez, P., Evans, E. G. V., Hawkey, P. M., Herbrecht, R., Marks, D. I., Moraleda, J. M., et al. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80125-x · Cited by 190
Ostrosky-Zeichner, L., Kontoyiannis, D., Raffalli, J., Mullane, K. M., Vazquez, J., Anaissie, E. J., Lipton, J., Jacobs, P., Rensburg, J. H. J., Rex, J. H., et al. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0024-8 · Cited by 189
Management and outcome of bloodstream infections due to Candida species in England and Wales
Kibbler, C. C., Seaton, S., Barnes, R. A., Gransden, W. R., Holliman, R. E., Johnson, E. M., Perry, J. D., Sullivan, D. J., & Wilson, J. A. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00085-9 · Cited by 187
In Vitro Activities of Four Novel Triazoles against Scedosporium spp
Carrillo, A. J., & Guarro, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2151-2153.2001 · Cited by 182
Schwartz, S., Behre, G., Heinemann, V., Wandt, H., Schilling, E. C., Arning, M., Trittin, A., Kern, W. V., Boenisch, O., Bosse, D., et al. (1999) · PubMed · doi:10.1182/blood.v93.11.3654 · Cited by 165
Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L., Hollis, R. J., & Jones, R. N. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.78-83.2003 · Cited by 165
Fungal Infections in Patients with Severe Acute Pancreatitis and the Use of Prophylactic Therapy
De Waele, J. J., Vogelaers, D., Blot, S., & Colardyn, F. (2003) · Clinical Infectious Diseases · doi:10.1086/375603 · Cited by 156
Tobón, Á. M., Arango, M., Fernández, D., & Restrepo, Á. (2003) · Clinical Infectious Diseases · doi:10.1086/375075 · Cited by 151
Epidemiology of Aspergillus terreus at a University Hospital
Baddley, J. W., Pappas, P. G., Smith, A. C., & Moser, S. A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5525-5529.2003 · Cited by 147
Cornely, O. A., Ullmann, A. J., & Karthaus, M. (2003) · Blood · doi:10.1182/blood-2002-05-1356 · Cited by 137
Vardakas, K. Z., Michalopoulos, A. S., & Falagas, M. E. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05727.x · Cited by 129
Treatment ofScedosporium apiospermumBrain Abscesses with Posaconazole
Mellinghoff, I. K., Winston, D. J., Mukwaya, G., & Schiller, G. J. (2002) · Clinical Infectious Diseases · doi:10.1086/340522 · Cited by 121
Management of deepCandida infection in surgical and intensive care unit patients
British Society for Antimicrobial Chemotherapy Working Party, & Denning, D. W. (1994) · Intensive Care Medicine · doi:10.1007/bf01711909 · Cited by 121
Tortorano, A. M., Biraghi, E., Astolfi, A., Ossi, C., Tejada, M., Farina, C., Perin, S., Bonaccorso, C., Cavanna, C., Raballo, A., et al. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1261 · Cited by 116
The epidemiology and prevention of invasive aspergillosis
Manuel, R. J., & Kibbler, C. C. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90323-1 · Cited by 115
Changes in susceptibility to posaconazole in clinical isolates of Candida albicans
Li, X., Brown, N., Chau, A. S., López-Ribot, J. L., Ruesga, M. T., Quindos, G., Mendrick, C. A., Hare, R. S., Loebenberg, D., DiDomenico, B., et al. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh027 · Cited by 97
Self-citationRosa, F. G. D., Shaz, D. J., Campagna, A. C., Dellaripa, P. F., Khettry, U., & Craven, D. E. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/502250 · Cited by 96
Caspofungin in Combination with Itraconazole for the Treatment of Invasive Aspergillosis in Humans
Rubin, M. A., Carroll, K. C., & Cahill, B. C. (2002) · Clinical Infectious Diseases · doi:10.1086/339755 · Cited by 77
Candidosis in the intensive care unit: a 20-year survey
Tortorano, A. M., Caspani, L., Rigoni, A. L., Biraghi, E., Sicignano, A., & Viviani, M. A. (2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.01.017 · Cited by 76
Fungal Infections in Solid Organ Transplant Patients
Hagerty, J. A., Ortiz, J., Reich, D. J., & Manzarbeitia, C. (2003) · Surgical Infections · doi:10.1089/109629603322419607 · Cited by 75
Laverdière, M., Hoban, D., Restieri, C., & Habel, F. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf074 · Cited by 73
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40
Nosocomial Cerebral Aspergillosis: A Report of 3 Cases
Darras-Joly, C., Veber, B., Bédos, J., Gachot, B., Regnier, B., & Wolff, M. (1996) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549609027182 · Cited by 36
Prophylactic Fluconazole in Liver Transplant Recipients
Singh, N., & Yu, V. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-10-200005160-00025 · Cited by 36
Cited by
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,373
Microbial drug discovery: 80 years of progress
Demain, A. L., & Sanchez, S. (2009) · The Journal of Antibiotics · doi:10.1038/ja.2008.16 · Cited by 1,002
Silver nanoparticles: synthesis, properties, toxicology, applications and perspectives
Tran, Q. H., Nguyen, V. Q., & Le, A.-T. (2013) · Advances in Natural Sciences: Nanoscience and Nanotechnology · doi:10.1088/2043-6262/4/3/033001 · Cited by 988
An integrated model of the recognition of Candida albicans by the innate immune system
Netea, M. G., Brown, G. D., Kullberg, B. J., & Gow, N. A. R. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1815 · Cited by 946
-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538
Metadata
- Authors
- Enoch, D. A., Ludlam, H. A., & Brown, N. M.
- Venue
- Journal of Medical Microbiology
- Publisher
- Microbiology Society
- Published
- 2006-07-01
- Volume
- 55
- Issue
- 7
- Pages
- 809-818
- ISSN
- 0022-2615 (ISSN-L)
- 1473-5644
- OpenAlex
- W2129227816
- Cited by
- 501
- References
- 82
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.